Business Context and Reporting Period
Biote Corp. filed a Form 8-K reporting executive management changes. The earliest reported event occurred on January 8, 2024; the filing was signed January 11, 2024. Biote is incorporated in Delaware, trades under the symbol BTMD on Nasdaq, and is an emerging growth company.
Key Financial Metrics and Capital Position
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial metrics. It is focused on executive appointments and transition arrangements.
Material Changes Versus the Prior Comparable Period
- Robert Peterson was appointed Chief Financial Officer, principal accounting officer, and principal financial officer, effective January 8, 2024.
- Samar Kamdar transitioned out of the CFO role effective immediately and was expected to remain employed through February 29, 2024, supporting the transition and special projects.
- The filing states that Mr. Kamdar’s transition was unrelated to the Company’s financial results or any disagreement concerning accounting principles, practices, or financial disclosures.
Compensation, Outlook, and Unusual Items
- Mr. Peterson’s employment agreement provides for an annual base salary of $425,000 and eligibility for an annual bonus of up to 50% of base salary.
- His initial equity award includes restricted stock units valued at $177,000 and 400,000 options to purchase Class A common stock, subject to the 2022 Equity Incentive Plan.
- Mr. Kamdar will continue receiving his current base salary during the transition period and may receive up to $140,000 in additional severance, subject to specified conditions.
- The full employment and transition agreements are expected to be filed as exhibits to Biote’s Form 10-K for the year ended December 31, 2023.
- The Company furnished a January 11, 2024 press release describing the management changes under Regulation FD. The filing provides no financial guidance or broader business outlook.
Important Facts for Investors to Verify
- Review the employment agreement for Mr. Peterson’s equity vesting, option terms, termination provisions, and other compensation conditions.
- Review the transition agreement for Mr. Kamdar’s severance conditions and the precise end of his employment.
- Confirm the final CFO transition status and any subsequent changes in the Company’s Form 10-K.
- Assess whether the management change affects financial reporting, internal controls, strategic execution, or future guidance; this 8-K does not identify such effects.